Why is Morepen Labs. falling/rising?

As of 16-Sep, Morepen Laboratories Ltd is experiencing a decline in its stock price, currently at 53.33, reflecting a decrease of 0.24 or 0.45%. The stock has underperformed its sector by 0.6% today and has been on a downward trend for the past three days, resulting in a total loss of 1.35%. Despite a positive performance over the past week and month, with returns of 4.04% and 14.91% respectively, the stock has faced significant challenges over the longer term, including a year-to-date decline of 31.89% and a one-year drop of 42.02%. The company's recent financial results have been disappointing, with net sales falling by 8.72% and consecutive negative results in the last two quarters, contributing to a lack of investor confidence.
In the broader market context, while the Sensex has shown a modest gain of 1.58% over the past week and 2.21% over the past month, Morepen Laboratories' recent performance has been starkly negative, indicating a significant underperformance relative to the market. The company's low debt-to-equity ratio and attractive valuation metrics, such as a 2.5 price-to-book value, suggest potential value; however, the lack of domestic mutual fund investment, which stands at 0%, raises concerns about the company's long-term growth prospects. Overall, the combination of poor financial results, declining investor participation, and underperformance against the benchmark has led to the stock's current downward movement.